Preclinical drug testing and assay development for lung adenocarcinoma characterized by the expression of ASCL1


About this study

The purpose of this study is to perform preclinical testing in patient samples and experimental models. 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Farhad Kosari, Ph.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015


More information


Publications are currently not available

Mayo Clinic Footer